Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo de conferência |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/52170 |
Resumo: | Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz. |
id |
CRUZ_7bff29846285547a32271c8e98935582 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/52170 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Sérgio, Sarah Aparecida RodriguesLourenço, Karine LimaAndrade, Luis Adan FloresBagno, Flávia FonsecaGazzinelli, Ricardo TostesFernandes, Ana Paula Salles MouraTeixeira, Santuza Maria RibeiroFonseca, Flávio Guimarães da2022-04-11T19:18:33Z2022-04-11T19:18:33Z2022SÉRGIO, S. A. R. et al. Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 69.https://www.arca.fiocruz.br/handle/icict/5217010.35259/isi.2022_52170Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. CT Vacinas. Belo Horizonte, MG, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosSARS-CoV-2ImunidadeAnticorpos neutralizantesSARS-CoV-2Neutralizing antibodiesImmunityVacinasDetermination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinatedinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/52170/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALAnais6thISI2022_69.pdfAnais6thISI2022_69.pdfapplication/pdf132265https://www.arca.fiocruz.br/bitstream/icict/52170/2/Anais6thISI2022_69.pdf76c8fc0604779cb7d836a5cd9beaad6aMD52icict/521702023-04-26 16:55:48.477oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:55:48Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
title |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
spellingShingle |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated Sérgio, Sarah Aparecida Rodrigues SARS-CoV-2 Imunidade Anticorpos neutralizantes SARS-CoV-2 Neutralizing antibodies Immunity Vacinas |
title_short |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
title_full |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
title_fullStr |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
title_full_unstemmed |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
title_sort |
Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated |
author |
Sérgio, Sarah Aparecida Rodrigues |
author_facet |
Sérgio, Sarah Aparecida Rodrigues Lourenço, Karine Lima Andrade, Luis Adan Flores Bagno, Flávia Fonseca Gazzinelli, Ricardo Tostes Fernandes, Ana Paula Salles Moura Teixeira, Santuza Maria Ribeiro Fonseca, Flávio Guimarães da |
author_role |
author |
author2 |
Lourenço, Karine Lima Andrade, Luis Adan Flores Bagno, Flávia Fonseca Gazzinelli, Ricardo Tostes Fernandes, Ana Paula Salles Moura Teixeira, Santuza Maria Ribeiro Fonseca, Flávio Guimarães da |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Sérgio, Sarah Aparecida Rodrigues Lourenço, Karine Lima Andrade, Luis Adan Flores Bagno, Flávia Fonseca Gazzinelli, Ricardo Tostes Fernandes, Ana Paula Salles Moura Teixeira, Santuza Maria Ribeiro Fonseca, Flávio Guimarães da |
dc.subject.other.pt_BR.fl_str_mv |
SARS-CoV-2 Imunidade Anticorpos neutralizantes |
topic |
SARS-CoV-2 Imunidade Anticorpos neutralizantes SARS-CoV-2 Neutralizing antibodies Immunity Vacinas |
dc.subject.en.pt_BR.fl_str_mv |
SARS-CoV-2 Neutralizing antibodies Immunity |
dc.subject.decs.pt_BR.fl_str_mv |
Vacinas |
description |
Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz. |
publishDate |
2022 |
dc.date.accessioned.fl_str_mv |
2022-04-11T19:18:33Z |
dc.date.available.fl_str_mv |
2022-04-11T19:18:33Z |
dc.date.issued.fl_str_mv |
2022 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
format |
conferenceObject |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SÉRGIO, S. A. R. et al. Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 69. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/52170 |
dc.identifier.doi.none.fl_str_mv |
10.35259/isi.2022_52170 |
identifier_str_mv |
SÉRGIO, S. A. R. et al. Determination of neutralizing antibodies to sars-cov-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 69. 10.35259/isi.2022_52170 |
url |
https://www.arca.fiocruz.br/handle/icict/52170 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Fiocruz/Instituto de Tecnologia em Imunobiológicos |
publisher.none.fl_str_mv |
Fiocruz/Instituto de Tecnologia em Imunobiológicos |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/52170/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/52170/2/Anais6thISI2022_69.pdf |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 76c8fc0604779cb7d836a5cd9beaad6a |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009249678131200 |